Browsing Category
Thickener
High mobility group box 1 cytokine targeted topical delivery of resveratrol embedded nanoemulgel for…
Resveratrol is a polyphenolic compound showing anti-inflammatory activity by inhibition of high mobility group box 1 cytokine responsible for the activation of nuclear factor-κB pathway in atopic dermatitis. To evaluate the efficacy of resveratrol through topical route we have developed…
Read More...
Read More...
Enhancing Drug Efficacy: Gattefossé’s Expertise in Excipient Selection
About our company
The Gattefossé Group is a community of employees, all driven by a dual mission: the performance of its products and the personalized support to its customers. Gattefossé develops, manufactures and sells cosmetic ingredients and pharmaceutical excipients of natural origin for…
Read More...
Read More...
Skin-friendly textures – by Gattefossé
Caring for patients
Patient preferences and needs as well as therapeutic indication should be considered at early stage of development of topical or transdermal formulations.
To increase adherence to skin treatments, it is important to consider patient’s needs, when designing the dosage…
Read More...
Read More...
Development of a New Jelly Coating Technology (Oral Jelly Coating) to Improve Prescribed Medication…
Oral drug delivery is currently the gold standard in the pharmaceutical industry, regarded as the safest, most convenient and most economical method of drug delivery with the highest patient compliance . Among oral formulations, tablets and capsules are the most preferred dosage forms, but there are…
Read More...
Read More...
Topical Drug Delivery – Excipients for creams, gels, and lotions
Stable and efficient semisolid preparations with optimal skin-feel have become the desirable standard in topical and
transdermal drug delivery. Lubrizol Life Science Health (LLS Health) has long-standing experience with semisolids,
offering rheology-modifying, emulsifying and bioadhesive…
Read More...
Read More...
Accelerating Topical Drug Development Through Initial Excipient Selection
See the poster presented by Seppic at DDF Summit in Berlin in June 2023:
Introduction
Novel topical drug development will require multiple formulation adjustments from the initial formulation studies to the registration phase .
Common issues encountered are API chemical instability, API lack…
Read More...
Read More...
Dual-Drug-Loaded Topical Delivery of Photodynamically Active Lipid-Based Formulation for Combination…
Topical administration of anti-cancer drugs along with photodynamically active molecules is a non-invasive approach, which stands to be a promising modality for treating aggressive cutaneous melanomas with the added advantage of high patient compliance. However, the efficiency of delivering drugs…
Read More...
Read More...
The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems
Abstract
Self-emulsification is considered a formulation technique that has proven capacity to improve oral drug delivery of poorly soluble drugs by advancing both solubility and bioavailability. The capacity of these formulations to produce emulsions after moderate agitation and dilution by means…
Read More...
Read More...
Development, QbD based optimization and in vitro characterization of Diacerein loaded nanostructured…
Abstract
Objective
DCN is a chondro-protective agent which displays inadequate oral bioavailability along with gastrointestinal side effects. It is a choice of drug for treatment of osteoarthritis. Therefore, the objective of this study was to develop and optimize DCN loaded nanostructured lipid…
Read More...
Read More...
A new perspective for psoriasis: Dithranol nanosponge loaded hydrogels
We developed dithranol nanosponge integrated Carbopol hydrogel (DTHNS-HG) as a novel perspective for psoriasis management. Dithranol was chosen as antipsoriatic moiety for this system. In this study, our objective was to fabricate and evaluate DTHNS-HG for in vivo anti-psoriatic activity using mouse…
Read More...
Read More...